In a significant move to address health concerns associated with soda consumption, the Food and Drug Administration (FDA) has proposed the prohibition of brominated vegetable oil (BVO) as an ingredient in citrus-flavored sodas across the United States. BVO, a modified vegetable oil used as an emulsifying agent in sodas since the 1930s, has come under scrutiny due to recent toxicology studies raising doubts about its safety.

James Jones, FDA’s deputy commissioner for human foods, emphasized the agency’s commitment to monitoring emerging evidence and taking regulatory action when necessary to ensure food safety. The proposal to revoke BVO’s registration follows mounting evidence suggesting potential health risks associated with its consumption.

BVO is known for its ability to evenly distribute citrus flavoring agents throughout beverages. However, concerns have been raised regarding its accumulation in human fat tissues over time and its potential interference with thyroid function due to bromine’s effects on iodine.

While BVO has been banned in several countries, including India, Japan, and nations of the European Union, the FDA’s stance has been cautious. Initially classified as generally recognized as safe (GRAS) in the 1950s, the FDA reversed its decision in the following decade amid concerns about toxicity. Subsequently, BVO’s use was restricted to low concentrations in citrus-flavored drinks.

However, recent studies have provided compelling evidence of potential health risks associated with even small amounts of BVO. Studies dating back to the 1970s revealed bromine accumulation in human tissues and suggested links between high BVO concentrations and heart and behavioral issues in animals.

The FDA’s proposal marks a significant step in addressing these concerns, although the reclassification of BVO still requires a thorough review process. Major soda manufacturers such as PepsiCo and Coca-Cola Co. have already taken steps to phase out BVO from their products over the past decade, indicating a proactive approach to addressing consumer health concerns.

Moreover, the FDA’s move signals a broader review of food additive regulations, with Jones announcing plans to scrutinize regulations authorizing certain additives, including food coloring agents, to ensure they do not pose cancer risks to humans or animals. This proactive approach aims to streamline regulatory processes and prioritize consumer health and safety.

While the final decision on BVO’s reclassification awaits completion of the review process, the proposal underscores the FDA’s commitment to addressing emerging health concerns and promoting safer food practices. With alternative ingredients already in use to maintain citrus flavor in sodas, the proposed ban on BVO is poised to contribute to a healthier beverage landscape in the United States.